Exercise capacity · promoting recovery of function after stroke
1 finding from 1 review
Balance ( · promoting recovery of function after stroke
1 finding from 1 review
Adverse events · promoting recovery of function after stroke
Motor neuroprosthesis may leads to higher adverse events compared with another assistive technology device (low certainty).
1 finding from 1 review
All‐cause mortality (at end of
Starches showed no clear difference in all‐cause mortality (at end of compared with crystalloid (moderate certainty).
1 finding from 1 review
All‐cause mortality (at 90 days)
Starches showed no clear difference in all‐cause mortality (at 90 days) compared with crystalloid (moderate certainty).
1 finding from 1 review
All‐cause mortality (within 30 days)
Starches showed no clear difference in all‐cause mortality (within 30 days) compared with crystalloid (moderate certainty).
1 finding from 1 review
Transfusion of blood products
Starches probably leads to higher transfusion of blood products compared with crystalloid (moderate certainty).
1 finding from 1 review
Renal replacement therapy
Starches probably leads to higher renal replacement therapy compared with crystalloid (moderate certainty).
1 finding from 1 review
Adverse events
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Adverse events (common reactions to aromatherapy include skin rashes, dyspnoea, headache, cardiac arrhythmias, hypotension, hypertension or dizziness) · adults and children having any type of surgical procedure under general anaesthesia, regional anaesthesia or sedation, as hospital…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (common reactions to aromatherapy include skin rashes, dyspnoea, headache, cardiac arrhythmias, hypotension, hypertension or dizziness) · adults and children having any type of surgical procedure under general anaesthesia, regional anaesthesia or sedation, as hospital…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (common reactions to aromatherapy include skin rashes, dyspnoea, headache, cardiac arrhythmias, hypotension, hypertension or dizziness) · adults and children having any type of surgical procedure under general anaesthesia, regional anaesthesia or sedation, as hospital…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (common reactions to aromatherapy include skin rashes, dyspnoea, headache, cardiac arrhythmias, hypotension, hypertension or dizziness) · adults and children having any type of surgical procedure under general anaesthesia, regional anaesthesia or sedation, as hospital…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Chest tightness · adults and children undergoing general anaesthesia including the muscle relaxant rocuronium bromide
It is very uncertain whether adverse effects of pharmacological intervention changes chest tightness compared with control (very low certainty).
1 finding from 1 review
Hot flush frequency (number/day) · women with hot flushes
Transdermal beta‐estradiol patch showed no clear difference in frequency of hot flushes Beta‐estradiol patch 0.0375‐0.10 mg/day compared with placebo (low certainty).
1 finding from 1 review
Change in frequency of hot flushes from baseline to end of study · women with hot flushes
Intranasal beta‐estradiol showed no clear difference in frequency of hot flushes Change from baseline Intranasal… compared with placebo (moderate certainty).
1 finding from 1 review
Hot flush frequency (number/day) · women with hot flushes
1 finding from 1 review
Frequency of hot flushes Oral beta‐estradiol 1.0 and 2.0 mg/day vs CEE 0.625 or 1.25 mg/day · women with hot flushes
1 finding from 1 review
Intensity of hot flushes Beta‐estradiol patch 0.025‐0.05 mg/day · women with hot flushes
Transdermal beta‐estradiol patch showed no clear difference in intensity of hot flushes Beta‐estradiol patch 0.025‐0.05 mg/day compared with placebo (low certainty).
1 finding from 1 review
Hot flush frequency (number/day) · women with hot flushes
1 finding from 1 review